Treatment of recurrent Clostridium difficile-associated disease.
about
Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated diseaseProbiotics and Gastrointestinal Disease: Clinical Evidence and Basic ScienceEffectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.Potential use of inhibitors of bacteria spore germination in the prophylactic treatment of anthrax and Clostridium difficile-associated disease.Clostridium difficile associated infection, diarrhea and colitisClinical update for the diagnosis and treatment of Clostridium difficile infection.Treatment of refractory and recurrent Clostridium difficile infection.Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review.The host immune response to Clostridium difficile infectionAntibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases.Fecal transplantation for the treatment of recurrent clostridium difficile infection.Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection.Selecting against antibiotic-resistant pathogens: optimal treatments in the presence of commensal bacteria.[Probiotics - is there evidence for use against antibiotic induced diarrhea, CDAD and travellers diarrhea?]Extended duration vancomycin in recurrent infection: a systematic review
P2860
Q26851409-8AB89660-53DC-4DF6-966B-374743632F81Q34162963-858839FD-5EB7-4C24-915C-3EF7269A5839Q35605686-21035108-1CD3-4504-951A-9A043177057EQ36960043-1EB9B911-BAC8-42A4-AB00-72F233932839Q37160538-8D2B4DBC-59CF-4236-B5C1-B502FC67C372Q37633859-62C918C8-BBD9-42C2-8D5F-E27204E0AC17Q37866629-27CDF722-C32C-4E63-B8FA-6EBB8FD58F87Q38097440-B1472057-D78C-4CD6-9F68-98A66963209DQ38244134-92461FB1-218A-4551-AC00-3B07E4C68FF2Q39640585-877D5F88-29A0-4D70-BC39-B30D76DFF66AQ42097408-2AEBF9D5-B40E-4C15-AD6E-C704D6E2F115Q42184661-3A1AAE33-E357-44E6-97F7-B3F64700F432Q42668739-992AAD28-EEB4-4AF2-BEFF-75A1238D64F1Q51504040-DA523D05-4CAD-464F-BBF1-0D6FCF307067Q53765712-DFB60797-4EE9-4852-A268-636CC62749CBQ59138438-A132A941-03F0-43FE-85E1-0A5C23345CD9
P2860
Treatment of recurrent Clostridium difficile-associated disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Treatment of recurrent Clostridium difficile-associated disease.
@ast
Treatment of recurrent Clostridium difficile-associated disease.
@en
type
label
Treatment of recurrent Clostridium difficile-associated disease.
@ast
Treatment of recurrent Clostridium difficile-associated disease.
@en
prefLabel
Treatment of recurrent Clostridium difficile-associated disease.
@ast
Treatment of recurrent Clostridium difficile-associated disease.
@en
P2860
P356
P1476
Treatment of recurrent Clostridium difficile-associated disease.
@en
P2093
Christina M Surawicz
P2860
P2888
P356
10.1038/NCPGASTHEP0018
P407
P577
2004-11-01T00:00:00Z